Mave Health has raised $2.1 million to develop a wearable headset designed to improve attention, mood and stress regulation through non-invasive brain stimulation.
The company is preparing to launch the device in 2026, targeting consumers looking for tools to manage cognitive performance and emotional state in real time.
The funding reflects growing interest in neurotechnology as a consumer category, moving beyond clinical settings into everyday use.
What is a neurostimulation headset?
A neurostimulation headset is a wearable device that delivers low-level electrical currents to specific regions of the brain to influence neural activity associated with functions such as attention, mood and cognitive control.
These systems typically use transcranial direct current stimulation (tDCS), a method that applies a weak electrical current through electrodes placed on the scalp.
The goal is to modulate neural excitability, making certain brain regions more or less likely to activate.
Non-invasive brain stimulation technology and tDCS explained
Mave’s device is built around non-invasive brain stimulation, meaning it does not require surgery or implanted hardware.
tDCS works by passing a low-intensity electrical current between electrodes, subtly altering the electrical environment of neurons. This can influence how easily neurons fire, which in turn may affect cognitive and emotional processes.
The approach has been studied in clinical and research settings for applications including depression, attention disorders and cognitive enhancement.
Consumer devices are now attempting to translate these findings into wearable formats that can be used outside controlled environments.
Consumer neurotech wearables targeting mood and attention
The strategic shift here is the movement of neurostimulation into consumer-grade products.
Historically, brain stimulation technologies have been confined to medical or research contexts. Devices required clinical supervision, and use cases were narrowly defined.
Startups like Mave are repositioning the technology as a daily-use tool for:
- improving focus during work
- regulating stress and emotional state
- supporting mental performance in high-demand environments
This aligns with broader demand for tools that address cognitive load, distraction and mental fatigue, particularly in digitally intensive work environments.
Convergence of mental health, performance and wearable technology
Mave’s positioning sits at the intersection of three converging categories:
- mental health support
- cognitive performance optimisation
- wearable technology
That convergence is shaping a new class of products focused on internal state regulation rather than external activity tracking.
Traditional wearables measure outputs such as movement, heart rate or sleep. Neurotech wearables aim to intervene directly in the systems that generate those outputs.
This represents a different model of interaction. Instead of observing the body and suggesting changes, the device attempts to influence the underlying neural processes.
Future implications for consumer neurotechnology
Over the next five to 10 years, products like Mave’s headset point toward a broader expansion of neurotechnology into consumer markets.
Several patterns are emerging.
First, brain-computer interfaces and neurostimulation are becoming more accessible. Advances in hardware design and miniaturisation are making it possible to package complex technologies into wearable formats.
Second, mental performance is becoming a target for optimisation. As work becomes more cognitively demanding, tools that influence focus and emotional regulation are gaining relevance.
Third, the boundary between medical and consumer devices is becoming less distinct. Technologies developed for clinical use are being adapted for everyday applications, raising new questions around safety, efficacy and regulation.
If adoption increases, neurotech could become a new layer in the wearable ecosystem, complementing biometric tracking with direct intervention.
The long-term significance is not just improved focus or mood. It is the emergence of devices that interact directly with the brain as part of daily health and performance routines, extending the scope of what consumer health technology can measure and influence.
